Trial · NCT02004652
Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery
NCT02004652, Phase 2, Completed, Jinling Hospital, China
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery. Trials, record NCT02004652. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02004652
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery
- NCT number
- NCT02004652
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 110 participants, actual
- Lead sponsor
- Jinling Hospital, China
- Conditions
- Postoperative Ileus
- Interventions
- Prucalopride, Placebo
- First posted
- 2013-12-09
- Last updated
- 2016-09-30
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to defaecation, measured in hours, from the time the surgery ends till the first observed passage of stool | up to 30 days after surgery | |
| Secondary | Time of first passing flatus reported by the patients(hours) | up to 30 days after surgery | |
| Secondary | Time to resume solid diet or total enteral nutrition(TEN)(days) | up to 30 days after surgery | |
| Secondary | Length of postoperative hospital stay (LOS)(days) | participants will be followed for the duration of postoperative hospital stay, an expected average of 8 days | |
| Secondary | Overall post-operative complication rate defined according to the Clavien-Dindo Classification | up to 30 days after surgery | |
| Secondary | Overall cost (RMB) | participants will be followed for the duration of postoperative hospital stay, an expected average of 8 days | |
| Secondary | Pain scores on visual analogue scale (from 0 which implies no pain at all, to 10 which implies the worst pain imaginable) on the first 3 postoperative days and postoperative analgesic requirement (number of doses on 50-mg Pethidine) | up to postoperative day 3 | |
| Secondary | Time to walk independently(days) | up to 30 days after surgery | |
| Secondary | Hospital Readmission Rates Post 30-day Discharge | up to 30 days after discharge | |
| Secondary | Length of postoperative ICU stay (days) | up to 30 days after surgery |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 26880227 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02004652
GET https://conductscience.org/api/trials/v1/NCT02004652/registered